Impact of programmed death‐ligand 1 (PD‐L1) positivity on clinical and molecular features of patients with metastatic gastric cancer

Impact of programmed death‐ligand 1 (PD‐L1) positivity on clinical and molecular features of patients with metastatic gastric cancer

Abstract Background Programmed death‐ligand 1 (PD‐L1) is an important screening biomarker to select patients with gastric cancer (GC) for optimized treatment, including immune checkpoint inhibitors (ICI). Methods In this single‐institution retrospective cohort study, patients with metastatic GC with...

Full description

Bibliographic Details
Main Authors: Minkyue Shin, Soomin Ahn, Jaeyun Jung, Sujin Hyung, Kyoung‐Mee Kim, Seung Tae Kim, Won Ki Kang, Jeeyun Lee
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Cancer Medicine
Subjects:
combined positive score
Epstein–Barr virus
gastric cancer
immune checkpoint inhibition
microsatellite instability
next‐generation sequencing
Online Access:https://doi.org/10.1002/cam4.6472

Internet

https://doi.org/10.1002/cam4.6472

Similar Items